Results 171 to 180 of about 113,976,979 (200)

Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability. [PDF]

Virulence
Wang X, Pu F, Yang X, Feng X, Zhang J, Duan K, Nian X, Ma Z, Ma XX, Yang XM.   +9 more
europepmc   +1 more source

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network. [PDF]

Influenza Other Respir Viruses
Rose AMC, Pozo F, Martínez-Baz I, Mazagatos C, Bossuyt N, Cauchi JP, Petrović G, Loghin II, Vaikutyte R, Buda S, Machado A, Duffy R, Oroszi B, Howard J, Echeverria A, Andreu C, Barbezange C, Džiugytė A, Nonković D, Popescu CP, Majauskaite F, Tolksdorf K, Gomez V, Domegan L, Horváth JK, Castilla J, García M, Demuyser T, Borg ML, Tabain I, Lazar M, Kubiliute I, Dürrwald R, Guiomar R, O'Donnell J, Kristóf K, Nicolay N, Bacci S, Kissling E, VEBIS SARI VE network team, Belgium SARI Surveillance Network (BelsariNet).   +40 more
europepmc   +1 more source

Correction: antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023. [PDF]

Virol J
Fossum E, Rohringer A, Aune T, Rydland KM, Bragstad K, Hungnes O.   +5 more
europepmc   +1 more source

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania [PDF]

Open Medicine (Poland), 2016
Abstract The objective of this study is to describe the clinical and epidemiological characteristics of patients hospitalized in Lithuania who are infected with influenza A(H1N1)pdm09 and to compare pandemic A(H1N1) pdm09 infection with postpandemic.
Stefan Gravenstein, Ligita Jancoriene, Daiva Radzišauskienė   +2 more
exaly   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Influenza A(H1N1)pdm09: beyond the pandemic

Enfermedades Infecciosas y Microbiología Clínica, 2012
On August 2010, the World Health Organization declared the end to the 2009 A(H1N1) pandemic. However, influenza A(H1N1)pdm09 continues to circulate as a seasonal virus. Different viruses have predominated in different parts of the world. To date, influenza A(H1N1)pdm09 has demonstrated little antigenic drift, and its oseltamivir resistance has remained
Diego, Viasus, Andrés, Antón, Tomás, Pumarola, Jordi, Carratalà   +3 more
openaire   +2 more sources

Influenza A(H1N1)pdm09-related pneumonia and other complications

Enfermedades Infecciosas Y Microbiología Clínica, 2012
Influenza A(H1N1)pdm09 virus infection was associated with significant morbidity, mainly among children and young adults. The majority of patients had self-limited mild-to-moderate uncomplicated disease. However, some patients developed severe illness and some died.
Viasus D, Jordi Carratala
exaly   +3 more sources

Distribution of A(H1N1)pdm09 Influenza Vaccine

Journal of Correctional Health Care, 2014
To identify factors associated with vaccine receipt among correctional facilities during the A(H1N1)pdm09 influenza pandemic, this study surveyed one third of U.S. correctional facilities. Analysis of the association of average daily population (ADP) on A(H1N1)pdm09 influenza vaccine receipt found that an ADP increase of 100 inmates resulted in a 32 ...
Anne Spaulding, Katherine Seib, Saad Ömer   +2 more
exaly   +3 more sources

Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09

Journal of Clinical Virology, 2013
Influenza virus affects millions of people worldwide each year. More severe infection occurs in the elderly, very young and immunocompromised. In 2009, a new variant of swine origin (influenza A(H1N1)pdm09 virus) emerged that produced severe disease in young healthy adults.The aim of this study was to determine whether cytokine concentrations are ...
W Carman, C McSharry, R Gunson
exaly   +3 more sources

The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients

Enfermedades Infecciosas y Microbiología Clínica, 2012
Before the advent of the influenza A(H1N1)pdm virus in 2009, the information available about the clinical manifestations and prognosis of influenza in immunosuppressed patients was scarce. With the 2009 pandemic, knowledge of the behavior, severity and importance of antiviral therapy for influenza A infection in immunocompromised hosts has increased ...
Elisa, Cordero, Julián, de la Torre-Cisneros, Asunción, Moreno, Pilar, Pérez-Romero, Melchor, Riera   +4 more
openaire   +2 more sources

Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza

New England Journal of Medicine, 2011
Community circulation of an oseltamivir-resistant strain of the novel pandemic influenza A (H1N1) virus has been identified in Australia.
Aeron C, Hurt, Kate, Hardie, Noelene J, Wilson, Yi-Mo, Deng, Maggi, Osbourn, Nicole, Gehrig, Anne, Kelso   +6 more
openaire   +2 more sources